If you suffer from recurring panic attacks and would like to help in the development of treatments, Novatrials is now running a clinical trial of a potential new treatment aimed …
CONDITION: Mental Health
GENDER:
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment.
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials is now running a clinical trial of a potential treatment aimed at alleviating the symptoms of PN. If you are currently diagnosed with PN, would like to help in …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Novatrials is now running a clinical study of a potential new treatment aimed at alleviating the symptoms of hyperuricemia. If you suffer with hyperuricemia or high serum uric acid, you …
CONDITION: Blood
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Closed: follow-up continuing
Novatrials is seeking volunteers who are overweight to join a clinical study of a potential new weight loss treatment. Under expert medical supervision, participants will explore an innovative new treatment …
CONDITION: Diet and Nutrition
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with vitiligo to join a clinical trial of a potential new treatment. If you are over 18 years of age, either male or female and have …
CONDITION: Inflammatory and Immune System
GENDER:
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Novatrials are seeking volunteers with known heart conditions to join a clinical trial of a potential new treatment. If you are at least 18 years of age, either male or …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with early symptoms of COVID-19 to join a clinical study of a potential new treatment. This treatment may help improve symptoms, and/or shorten the duration of …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
We are seeking participants male or female and over 18 years of age, that have been on a stable dose of antihistamine with continued symptoms. Active treatment for the trial …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Participating in a clinical trial is about helping others. You will be helping in the development of new medications which will help improve or even save the lives of people …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Alopecia If you are at least 18 years of age, either male or female and: * currently have at least 20% scalp hair loss * you are able to attend …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials are seeking volunteers to join a Basal Cell Carcinoma (BCC) clinical trial for a potential new anti-cancer treatment injected directly into the tumour. We want to hear from you …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
FB102-701: A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Severe to Very Severe Alopecia Areata
CONDITION: Skin
GENDER: All
AGE GROUP: 18 to 75 years
TRIAL STATUS: Not yet recruiting
A Phase 2, Randomized, Open-label, Active- and Vehicle-controlled Comparator Study to Assess the Safety, Tolerability, and Efficacy of 2.4% Terbinafine Hydrochloride Topical Solution in Patients with Mild to Moderate Onychomycosis …
CONDITION: Skin
GENDER:
AGE GROUP: 18 to 70 years
TRIAL STATUS: Not yet recruiting
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
CONDITION: Skin
GENDER: All
AGE GROUP: 18 to 75 years
TRIAL STATUS: Active, not recruiting
A Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate a Switch to an Oral Weekly Islatravir/ Lenacapavir Regimen in People with HIV-1 Who are Virologically Suppressed on Standard of Care
CONDITION: Other
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
A Phase 3, Randomized, Active-controlled, Double-blind Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir (B/F/TAF)
CONDITION: Other
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
A Phase 3, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety and Immunogenicity of a SARS‑CoV‑2 rS Nanoparticle and Trivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine with Matrix-M™ Adjuvant and a …
CONDITION: Other
GENDER: All
AGE GROUP: 60 and above
TRIAL STATUS: Active, not recruiting
A Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Trial to Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects without Diabetes Mellitus
CONDITION: Metabolic and Endocrine
GENDER: All
AGE GROUP: 18 to 75 years
TRIAL STATUS: Active, not recruiting
Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
CONDITION: Mental Health
GENDER: All
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 …
CONDITION: Other
GENDER: All
AGE GROUP: 18 to 60 years
TRIAL STATUS: Recruiting
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
CONDITION: Infection
GENDER: Males
AGE GROUP: 18 to 50 years
TRIAL STATUS: Closed: follow-up complete
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 …
CONDITION: Other
GENDER: All
AGE GROUP: 18 to 60 years
TRIAL STATUS: Active, not recruiting
This is a phase III, randomized, multicenter, open-label study which will be performed to evaluate efficacy and safety of oral Gepotidacin compared to intramuscular (IM) ceftriaxone plus oral azithromycin for the treatment …
CONDITION: Infection
GENDER: All
AGE GROUP: 12 and above
TRIAL STATUS: Completed
A seven year plan of enhanced HCV monitoring, primary care–based workforce development, rapid scale-up of HCV treatment and public health policy action in HIV positive individuals within Australia.
CONDITION: Inflammatory and Immune System
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Completed
This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLAS-2M) study is designed to demonstrate the non-inferior antiviral activity and safety of CAB LA + RPV LA administered every …
CONDITION: Inflammatory and Immune System
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
A Phase 2 Randomized, Open-label Study to Evaluate the Safety and Efficacy of Broadly Neutralizing Antibodies (bNAbs) GS-5423 and GS-2872 in Combination With the Capsid Inhibitor Lenacapavir as Long-Acting Treatment …
CONDITION: Other
GENDER: All
AGE GROUP: 18 to 65 years
TRIAL STATUS: Active, not recruiting
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide …
CONDITION: Inflammatory and Immune System
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Completed